| Jonathan B Lau, DO | |
|
716 W Broadway, Glendale, CA 91204-1010 | |
| (818) 550-0900 | |
| (505) 293-1524 |
| Full Name | Jonathan B Lau |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 26 Years |
| Location | 716 W Broadway, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144367111 | NPI | - | NPPES |
| 00AX75450 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 20A7545 (California) | Primary |
| Entity Name | Pacific Valley Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851312862 PECOS PAC ID: 3577465368 Enrollment ID: O20040122000762 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.
A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.
Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.
According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."
› Verified 5 days ago
| Entity Name | Jbl Anesthesia Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114068145 PECOS PAC ID: 9931013653 Enrollment ID: O20110919000626 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.
A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.
Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.
According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."
› Verified 5 days ago
| Entity Name | Talbert Anesthesia Group Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144626714 PECOS PAC ID: 6406171461 Enrollment ID: O20150213001921 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.
A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.
Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.
According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."
› Verified 5 days ago
| Entity Name | Equity Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134746456 PECOS PAC ID: 1557786985 Enrollment ID: O20200803001132 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.
A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.
Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.
According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan B Lau, DO Po Box 5486, Orange, CA 92863-5486 Ph: (818) 550-0900 | Jonathan B Lau, DO 716 W Broadway, Glendale, CA 91204-1010 Ph: (818) 550-0900 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.
A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.
Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.
According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."
› Verified 5 days ago
Mrs. Asmik Akopyan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1030 S. Glendale Ave., Suite 404, Glendale, CA 91205 Phone: 818-240-9911 Fax: 818-240-9939 | |
Michael S Winston, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 824 N Glendale Ave, Glendale, CA 91206 Phone: 818-500-0523 | |
Dwight E Hiscox, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-550-0900 Fax: 505-293-1524 | |
Yukiko Ree, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1812 Verdugo Blvd, Glendale, CA 91208 Phone: 818-790-7100 | |
Arthur Victor Liu, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Varner Edward Dudley Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Ivan Hronek, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1420 S Central Ave, Glendale, CA 91204 Phone: 818-502-1900 Fax: 818-502-4738 |